Max Healthcare Institute shares decline 2.64% amid volume surge; stock among top losers on Nifty Midcap 150

Max Healthcare Institute Limited shares experienced a decline of 2.64%, trading at Rs 1,218.50 in Friday's session. This drop positions the stock among the top losers on the Nifty Midcap 150, with high trading volume and a surge in overall activity.

Financial Overview

Max Healthcare Institute Limited's financial performance shows consistent growth in both quarterly and annual results. The following tables summarize the company's financial data:

Consolidated Quarterly Results

HeadingMar 2024Jun 2024Sep 2024Dec 2024

Mar 2025RevenueRs 1,422.90 CroreRs 1,542.95 CroreRs 1,707.46 CroreRs 1,868.31 Crore

Rs 1,909.74 CroreNet ProfitRs 251.54 CroreRs 236.27 CroreRs 281.81 CroreRs 238.80 Crore

Rs 319.00 CroreEPS2.592.432.902.46

3.28

The quarterly revenue has shown a steady increase, culminating in Rs 1,909.74 Crore for the quarter ending March 2025. Similarly, the net profit reached Rs 319.00 Crore for the same period.

Consolidated Yearly Results

Heading2021202220232024

2025RevenueRs 2,504.67 CroreRs 3,931.46 CroreRs 4,562.60 CroreRs 5,406.02 Crore

Rs 7,028.46 CroreNet Profit-Rs 114.50 CroreRs 605.05 CroreRs 1,103.51 CroreRs 1,057.64 Crore

Rs 1,075.88 CroreEPS-1.596.2511.3810.89

11.07BVPS58.3764.7976.3186.51

96.50ROE-2.439.6314.8912.57

11.46Debt to Equity0.160.120.080.14

0.27

The annual revenue for Max Healthcare Institute Limited has grown consistently, reaching Rs 7,028.46 Crore in 2025, compared to Rs 5,406.02 Crore in 2024. Net profit also showed a substantial increase, from Rs 1,057.64 Crore in 2024 to Rs 1,075.88 Crore in 2025.

Consolidated Yearly Income Statement

Mar 2025Mar 2024Mar 2023Mar 2022

Mar 2021Sales7,0285,4064,5623,931

2,504Other Income155178139127

114Total Income7,1845,5844,7014,058

2,619Total Expenditure5,6124,1583,5543,219

2,508EBIT1,5711,4251,147839

110Interest1655983100

179Tax330307-39133

45Net Profit1,0751,0571,103605

-114

Consolidated Quarterly Income Statement

Mar 2025Dec 2024Sep 2024Jun 2024

Mar 2024Sales1,9091,8681,7071,542

1,422Other Income46334034

45Total Income1,9561,9011,7481,577

1,468Total Expenditure1,4981,5401,3411,232

1,111EBIT457361407345

356Interest55523323

20Tax83709185

84Net Profit319238281236

251

Cash Flow

Mar 2025Mar 2024Mar 2023Mar 2022

Mar 2021Operating Activities1,4591,1211,209748

117Investing Activities-1,631-1,285-1,187-771

-73Financing Activities-163-263-288-294

191Others173200

279Net Cash Flow-318-394-266-317

515

Balance Sheet

Mar 2025Mar 2024Mar 2023Mar 2022

Mar 2021Share Capital972971970969

965Reserves & Surplus8,4087,3686,3975,290

4,646Current Liabilities1,8131,2481,045757

776Other Liabilities4,0192,4101,6882,171

2,155Total Liabilities15,21411,99910,1019,189

8,544Fixed Assets8,9226,3844,8364,714

4,108Current Assets1,5921,7061,9431,000

1,124Other Assets4,6993,9093,3223,474

3,311Total Assets15,21411,99910,1019,189

8,544Contingent Liabilities1,3741,169326515

388

Key Financial Ratios

RatioMar 2021Mar 2022Mar 2023Mar 2024

Mar 2025Basic EPS (Rs.)-1.596.2511.3810.89

11.07Diluted Eps (Rs.)-1.596.2411.3610.84

11.01Book Value /Share (Rs.)58.3764.7976.3186.51

96.50Dividend/Share (Rs.)0.000.000.001.50

1.50Face Value10101010

10Gross Profit Margin (%)20.7027.2130.2430.89

28.51Operating Margin (%)13.7521.5825.1526.36

23.40Net Profit Margin (%)-4.5715.3824.1819.56

15.30Return on Equity (%)-2.439.6314.8912.57

11.46ROCE (%)4.4310.0612.6713.25

12.27Return On Assets (%)-1.606.5810.928.81

7.07Current Ratio (X)1.451.321.861.37

0.88Quick Ratio (X)1.381.241.791.30

0.82Debt to Equity (x)0.160.120.080.14

0.27Interest Coverage Ratios (X)1.9210.6116.4527.89

12.15Asset Turnover Ratio (%)29.310.220.220.49

0.52Inventory Turnover Ratio (X)46.560.000.000.00

0.003 Yr CAGR Sales (%)4,904.676,170.14107.5646.91

33.713 Yr CAGR Net Profit (%)970.052,359.78824.54203.92

33.35P/E (x)-129.4055.6238.7675.29

99.09P/B (x)3.535.355.789.48

11.37EV/EBITDA (x)38.8531.6530.3847.77

54.09P/S (x)7.958.569.3814.75

15.17

Corporate ActionsMax Healthcare Institute Limited has announced several corporate actions, including:

• Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
• Business Responsibility and Sustainability Report for the financial year 2024-25
• Notice of 24th Annual General Meeting and Integrated Annual Report for the financial year 2024-25

Additionally, the company declared a final dividend of Rs.1.50 per share (15%) with effective date as July 04, 2025.The stock’s movement occurred amid high trading volume on Friday. Moneycontrol analysis indicates a neutral sentiment for the stock.